DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
Public ClinicalTrials.gov record NCT00596583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AQNA-DY001: A Double-Masked, Randomized Study of the Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to test the hypothesis that DYME is safe and effective as a drug to facilitate continuous curvilinear capsulorhexis (CCC) by selectively staining the anterior capsule. Secondary objectives are to compare the safety and effectiveness of DYME to that of a smaller dose of the same API.
Study identification
- NCT ID
- NCT00596583
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2007
- Primary completion
- Apr 30, 2008
- Completion
- Apr 30, 2008
- Last update posted
- Mar 1, 2009
2007 – 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| McDonald Eye Associates | Fayetteville | Arkansas | 72703 | — |
| Peace Laser Eye Center | Inglewood | California | 90301 | — |
| Capitol City Surgery Center | Sacramento | California | 95815 | — |
| The Eye Institute of West Florida | Largo | Florida | 33770 | — |
| Center for Excellence in Eye Care | Miami | Florida | 33176 | — |
| Eye Surgeons of Indiana | Indianapolis | Indiana | 46256 | — |
| Silverstein Eye Centers | Kansas City | Missouri | 64133 | — |
| St. John's Clinic Eye Specialists | Springfield | Missouri | 65804 | — |
| Ballas Surgery Center | St Louis | Missouri | 63141 | — |
| Wills Eye Surgery Center | Cherry Hill | New Jersey | 08002 | — |
| Brar-Parekh Eye Associates | Woodland Park | New Jersey | 07424 | — |
| Island Eye Surgicenter | Carle Place | New York | 11514 | — |
| The Ohio State University Hospital | Columbus | Ohio | 43210 | — |
| Eye Care Specialists | Kingston | Pennsylvania | 18704 | — |
| Wills Eye Surgery Center | Philadelphia | Pennsylvania | 19107 | — |
| Wills Surgery Center | Philadelphia | Pennsylvania | 19145 | — |
| SMDV Surgery Center | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00596583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2009 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00596583 live on ClinicalTrials.gov.